http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004519443-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 |
| filingDate | 2001-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2004519443-A |
| titleOfInvention | Substituted pyrrolidines as CCR-3 receptor antagonists |
| abstract | The present invention provides a compound represented by the formula (I) wherein R 1 , R 2 , Ar 1 to Ar 3 , alk 1 , alk 2 , X and Y have the values indicated in the present specification. It relates to a specific 2,4-substituted pyrrolidine derivative. The compounds are useful as CCR-3 receptor antagonists and are therefore used in the treatment of diseases treatable by administration of CCR-3 receptor antagonists, such as asthma. |
| priorityDate | 2000-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.